Ronald Li, PhD
BSc Biochemistry /Biotechnology Specialization ‘94
CEO & Director, Novoheart Limited
Director of Ming-Wai Lau Centre for Reparative Medicine,
Karolinksa Institute, Hong Kong, Sweden
Professor Ronald Li is Director of the Ming-Wai Lau Center for Reparative Medicine, Karolinska Institute, Hong Kong. Additionally, he is affiliated with the Dr. Li Dak-Sum Center for Regenerative Medicine at Hong Kong University (HKU). Professor Li launched his career as an Assistant Professor at John Hopkins University. Later, as Associate Professor at the University of California Davis, he founded the Human Embryonic Stem Cell Consortium. He subsequently joined the Icahn School of Medicine, Mt Sinai, as co-director of Cardiovascular Cell & Tissue Engineering. In 2010 Professor Li became the founding director of the Stem Cell Biology & Regenerative Medicine Consortium as the SY and HY Cheng endowed professor at HKU..
Professor Li is the co-founder and CEO of Novoheart, a global Bio-pharmaceutical company which engineers bioartifical human heart prototypes using state-of-the-art stem cell and bioengineering approaches revolutionizing drug discovery and development, as well as cell-based regenerative heart therapies.
Professor Li has published over 150 research articles, received numerous accolades including Career Development Award Cardiac Arrhythmias Research & Education Foundation (2001), as well as the Young Investigator Award from the Heart Rhythm Society in 2002. John Hopkins University recognized him twice with Top Young Faculty Award (2002, 2004). He received the American Heart Association Best Study (2005) and Ground-breaking Study (2006).